Skip to main content
Clinical Trials/NL-OMON38711
NL-OMON38711
Withdrawn
Not Applicable

The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension. - VWF-TIPS study

niversitair Medisch Centrum Groningen0 sites16 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
16
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patient with cirrhosis undergoing TIPS placement
  • \- \>\=18 years of age
  • \- Signed informed consent

Exclusion Criteria

  • Patients with hemophilia A or von Willebrands disease

Outcomes

Primary Outcomes

Not specified

Similar Trials